ArticleScientific reports2025
XGBoost models based on non imaging features for the prediction of mild cognitive impairment in older adults.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Feature Selection Analysis and Robustness to Missing Data for Sensor-Based Prognostic Modeling of Alzheimer's Disease Progression.Sensors (Basel, Switzerland) · 2026Article
- Prediction of delirium in trauma patients using interpretable machine learning.Scientific reports · 2026Article
- Explainable Machine Learning Reveals Time-Dependent Cognitive Risk in Minor Neurocognitive Disorder: Implications for Health Promotion and Early Risk Stratification.Biomedicines · 2026Article
- Artificial intelligence algorithms for the prediction of cognitive decline and dementia: A theoretical-historical narrative review.Journal of Alzheimer's disease reportsReview
- AI-assisted screening for mild cognitive impairment using routine EHR data: a Gradient Boosting approach.Frontiers in neurologyArticle
- [Development of a machine learning-based model for assessing pulmonary function in elderly patients].Nan fang yi ke da xue xue bao = Journal of Southern Medical UniversityArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global increase in dementia cases highlights the importance of early detection and intervention, particularly for individuals at risk of mild cognitive impairment (MCI), a precursor to dementia. The aim of this study is to develop and validate machine learning (ML) models based on non-imaging features to predict the risk of MCI conversion in cognitively healthy older adults over a three-year period. Using data from 845 participants aged 65 to 87 years, we built five eXtreme Gradient Boosting (XGBoost) models of increasing complexity, incorporating demographic, self-reported, medical, and cognitive variables. The models were trained and evaluated using robust preprocessing techniques, including multiple imputation for missing data, Synthetic Minority Oversampling Technique (SMOTE) for class balancing, and SHapley Additive exPlanations (SHAP) for interpretability. Model performance improved with the inclusion of cognitive assessments, with the most comprehensive model (Model 5) achieving the highest accuracy (86%) and area under the curve (AUC = 0.8359). Feature importance analysis revealed that variables such as memory tests, depressive symptoms, and age were significant predictors of MCI conversion. In addition, an online risk calculator has been developed and made available free of charge to facilitate clinical use and provide a practical, cost-effective tool for early detection in diverse healthcare settings ( https://aimar-project.shinyapps.io/MCI-risk-calculator/ ). This study highlights the potential of non-imaging ML models for early detection of MCI and emphasizes their accessibility and clinical utility. Future research should focus on validating these models in different populations and examining their integration with personalized intervention strategies to reduce dementia risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.